Acute motor axonal neuropathy associated with COVID-19

Year 2022, Volume: 39 Issue: 1, 277 - 279, 01.01.2022

Mehlika Panpallı Ateş , Beyza Cetin Beria Ertugrul Ahmet Yuksektepe Selim Comoglu

Abstract

COVID-19, which is considered a global pandemic, is constantly being renewed. Acute motor axonal neuropathy (AMAN) is a rare, axonal variant of Guillain-Barré syndrome (GBS). This article presents a 69-year-old female patient diagnosed with AMAN due to a COVID-19 infection. Sixty-nine-year-old female patient who started myalgia, headache, cough 14 days ago, and was added diarrhea, fever, loss of smell and taste. Nasopharyngeal SARS-CoV-2 polymerase chain reaction (PCR) was found to be positive. Ten days later, numbness and weakness developed in the distal extremities. As a result of the patient's neurological examination, acute motor axonal neuropathy (AMAN) was diagnosed.

Keywords

Acute motor axonal neuropathy, Covid-19, Guillain-Barré syndrome, pandemic, SARS-CoV2

Supporting Institution

Yok

Project Number

Yok

Thanks

-

References

• 1. Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19–associated Guillain-Barré syndrome: The early pandemic experience. Muscle & Nerve. 2020; 62: 485–491. doi: 10.1002/mus.27024.
• 2. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020; 41: 3149–3156 https://doi.org/10.1007/s10072-020-04693-y
• 3. Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, Saboory E. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int J Neurosci. 2021:1-8. doi: 10.1080/00207454.2020.1849193.
• 4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683-690. doi: 10.1001/jamaneurol.2020.1127.
• 5. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020; 382(23): 2268-2270. doi: 10.1056/NEJMc2008597.
• 6. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literatüre. J Peripher Nerv Syst. 2020; 1-4. doi: 10.1111/jns.12382.
• 7. Ates MP, Dibek DM, Guven H, Comoglu SS. A Rare Complication of Bariatric Surgery; Guillain Barre Syndrome. J Clin Images. 2020; 3(1): 1051. doi: 10.33582/2690-8662/1051.
• 8. Panpalli Ates M, Guven H, Comoglu SS. Temporary conduction block in acute motor axonal neuropathy. Acta Neurol Belg. 2016; 116(3): 425-427. doi: 10.1007/s13760-015-0543-8.
• 9. Paybast S, Gorji R, Mavandadi S. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature. Neurologist. 2020; 25(4): 101-103. doi: 10.1097/NRL.0000000000000291.
• 10. Dalakas MC. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5): e781. doi:10.1212/NXI.0000000000000781